newsfilter
← Latest News
PR Newswire·

WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION

SUNNYVALE, Calif., Oct. 3, 2023 /CNW/ - Willow Biosciences Inc., ("Willow") (TSX:WLLW) (OTCQB:CANSF) and SUANFARMA today jointly announced execution of a collaboration agreement for a cell line productivity